Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

The Carlyle Group Inc. - Common Stock (NQ:CG)

51.40 +0.23 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,182,352
Open 51.38
Bid (Size) 51.39 (7)
Ask (Size) 51.40 (2)
Prev. Close 51.17
Today's Range 51.08 - 51.86
52wk Range 33.02 - 57.50
Shares Outstanding 354,462,148
Dividend Yield 2.72%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why KKR Stock Rocketed Almost 5% Higher Today
Via The Motley Fool
Topics Economy Government World Trade
Diversified Energy and Carlyle Enter Strategic Partnership to Invest in Up to $2 Billion of PDP Energy Assets
From Diversified Energy PLC
Via GlobeNewswire

Performance

YTD
+1.3%
+1.3%
1 Month
+13.7%
+13.7%
3 Month
+17.9%
+17.9%
6 Month
+1.7%
+1.7%
1 Year
+29.9%
+29.9%

More News

Read More
Is the Market Bullish or Bearish on Carlyle Group?
Via Benzinga
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
From bluebird bio, Inc.
Via Business Wire
Is Carlyle Group Gaining or Losing Market Support?
Via Benzinga
Price Over Earnings Overview: Carlyle Group
Via Benzinga
Carlyle Group Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Via Benzinga
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
From bluebird bio, Inc.
Via Business Wire
Carlyle CEO Harvey Schwartz Says 'Stay Buckled' Amid Market Turmoil – 'It's Just A Question Of Whether The Airbags Come Out
Via Benzinga
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
From bluebird bio, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Acentra Health Supports Utah in Securing CMS Certification for Medicaid Enterprise System Modernization
From Acentra Health
Via GlobeNewswire
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
From bluebird bio, Inc.
Via Business Wire
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
From Acentra Health
Via GlobeNewswire
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Bill Miller's Q4 Additions Struggle Amid Market Uncertainty, What Else Is Dragging Them Down?
Via Benzinga
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
From Acentra Health
Via GlobeNewswire
Is Carlyle Group Gaining or Losing Market Support?
Via Benzinga
SoftBank Buys Silicon Valley Firm As It Goes All-In On AI
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Masayoshi Son's SoftBank Buys Oracle-Backed Ampere For $6.5 Billion To Boost US AI Push
Via Benzinga
Topics Artificial Intelligence
Oppenheimer Analysts Slash Estimates For Goldman Sachs, Jefferies Amid Subdued M&A Activity
Via Benzinga
Tariffs Tangle Markets, Businesses, Investors
Via The Motley Fool
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Via Benzinga
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
Via Benzinga

Frequently Asked Questions

Is The Carlyle Group Inc. - Common Stock publicly traded?
Yes, The Carlyle Group Inc. - Common Stock is publicly traded.
What exchange does The Carlyle Group Inc. - Common Stock trade on?
The Carlyle Group Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for The Carlyle Group Inc. - Common Stock?
The ticker symbol for The Carlyle Group Inc. - Common Stock is CG on the Nasdaq Stock Market
What is the current price of The Carlyle Group Inc. - Common Stock?
The current price of The Carlyle Group Inc. - Common Stock is 51.40
When was The Carlyle Group Inc. - Common Stock last traded?
The last trade of The Carlyle Group Inc. - Common Stock was at 06/30/25 04:00 PM ET
What is the market capitalization of The Carlyle Group Inc. - Common Stock?
The market capitalization of The Carlyle Group Inc. - Common Stock is 18.22B
How many shares of The Carlyle Group Inc. - Common Stock are outstanding?
The Carlyle Group Inc. - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.